Hydroxytyrosol supplementation increases vitamin C levels in vivo. A human volunteer trial

Redox Biology

Volumn 11, Issue , 2017, Pages 384-389

  Lopez Huertas, Eduardo ^a   Fonolla, Juristo ^b  

^a CSIC   (Spain)

^b Biosearch Life SA   (Spain)

Author keywords

Antioxidant; Human study; Hydroxytyrosol; Olive oil; Polyphenolics; Vitamin c

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; AMYLASE; ANTIOXIDANT; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CREATINE KINASE; CREATININE; CYANOCOBALAMIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYTYROSOL; IRON; LACTATE DEHYDROGENASE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; PYRIDOXINE; RETINOL; TRANSFERRIN; TRIACYLGLYCEROL; UNINDEXED DRUG; UREA; URIC ACID; VITAMIN D; 3,4-DIHYDROXYPHENYLETHANOL; FOLIC ACID; LIPID; OLIVE OIL; PHENETHYL ALCOHOL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; ELECTROLYTE BALANCE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GOOD CLINICAL PRACTICE; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; IN VIVO STUDY; KIDNEY FUNCTION TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION TEST; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SPAIN; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; VITAMIN BLOOD LEVEL; AGONISTS; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; CHEMISTRY; CLINICAL TRIAL; DIETARY SUPPLEMENT; ISOLATION AND PURIFICATION; LIPID METABOLISM; PHYSIOLOGY;

ADULT; ASCORBIC ACID; BLOOD PRESSURE; BODY MASS INDEX; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HEALTHY VOLUNTEERS; HUMANS; IRON; KIDNEY FUNCTION TESTS; LIPID METABOLISM; LIPIDS; LIVER FUNCTION TESTS; MALE; OLIVE OIL; PHENYLETHYL ALCOHOL;

EID: 85008352471     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2016.12.014     Document Type: Article

References (45)

1. [1] Tripoli, E., Giammanco, M., Tabacchi, G., Di Majo, D., Giammanco, S., La Guardia, M., The phenolic compounds of olive oil: structure, biological activity and beneficial effects on human health. Nutr. Res. Rev. 18 (2005), 98–112, 10.1079/NRR200495.
2. [2] Visioli, F., Caruso, D., Galli, C., Viappiani, S., Galli, G., Sala, A., Olive oils rich in natural catecholic phenols decrease isoprostane excretion in humans. Biochem. Biophys. Res Commun. 278 (2000), 797–799.
3. [3] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL-cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), anti-inflammatory properties (ID 1882), contributes to the upper respiratory tract health (ID 3468), can help to maintain a normal function of gastrointestinal tract (3779), and contributes to body defences against external agents (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2033 [25 pp.]. doi: 10.2903/j.efsa.2011.2033. Available online: 〈www.efsa.europa.eu/efsajournal〉.
4. [4] Visioli, F., Caruso, D., Grande, S., Bosisio, R., Villa, M., Galli, G., Sirtori, C., Galli, C., Virgin olive oil study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur. J. Nutr. 6 (2004), 1–7.
5. [5] Fito, M., Gimeno, E., Covas, M.I., Miro, E., Lopez-Sabater, M.C., Farre, M., Marrugat, de I.T., J. postprandial and short-term effects of dietary virgin olive oil on oxidant/antioxidant status. Lipids 37 (2002), 245–251.
6. [6] Leger, C.L., Carbonneau, M.A., Michel, F., Mas, E., Monnier, L., Cristol, J.P., Descomps, B., A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. Eur. J. Clin. Nutr. 59 (2005), 727–730.
7. [7] Marrugat, J., Covas, M.I., Fito, M., Schroder, H., Miro-Casas, E., Gimeno, E., Lopez-Sabater, M.C., de la Torre, R., Farre, M., SOLOS Investigators, Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation-a randomized controlled trial. Eur. J. Nutr. 43 (2004), 140–147.
8. [8] Petroni, A., Blasevich, M., Salami, M., Papini, N., Montedoro, G.F., Galli, C., Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb. Res. 78 (1995), 151–160.
9. [9] Dell'Agli, M., Maschi, O., Galli, G.V., Fagnani, R., Dal Cero, E., Caruso, D., Bosisio, E., Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Br. J. Nutr. 99 (2008), 945–951.
10. [10] Moreno-Luna, R., Muñoz-Hernandez, R., Miranda, M.L., Costa, A.F., Jimenez-Jimenez, L., Vallejo-Vaz, A.J., Muriana, F.J., Villar, J., Stiefel, P., Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am. J. Hypertens. 25 (2012), 1299–1304, 10.1038/ajh.2012.128.
11. [11] González-Santiago, M., Martín-Bautista, E., Carrero, J.J., Fonollá, J., Baró, L., Bartolomé, M.V., Gil-Loyzaga, P., López-Huertas, E., One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis 188 (2006), 35–42.
12. [12] González-Santiago, M., Fonollá, J., Lopez-Huertas, E., Human absorption of a supplement containing purified hydroxytyrosol, a natural antioxidant from olive oil, and evidence for its transient association with low-density lipoproteins. Pharm. Res 61 (2010), 364–370, 10.1016/j.phrs.2009.12.016.
13. [13] Mataix, J., Mañas, M., Llopis, J., Martinez-Victoria, E., Tabla de composición de alimentos españoles. 1998, Universidad de Granada, Granada, Spain.
14. [14] Brenes, M., García, A., García, P., Rios, J.J., Garrido, A., Phenolic compounds in Spanish olive oils. J. Agric. Food Chem. 47 (1999), 3535–3540.
15. [15] Foot, E.A., Fry, I.D., Starkey, B.J., Measurement of plasma and urinary ascorbic acid by high performance liquid chromatography (HPLC). Ann. Clin. Biochem., 24, 1987 (Supplement: S1-225).
16. [16] Araki, A., Sako, Y., Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422 (1987), 43–52.
17. [17] Miller, J.N., Rice-Evans, C., Davies, M.J., Gopinathan, V., Milner, A., A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84 (1993), 407–412.
18. [18] Fukunaga, K., Yoshida, M., Nakazono, N., A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by highperformance liquid chromatography. Biomed. Chromatogr. 12 (1998), 300–303.
19. [19] Romero, C., Brenes, M., Yousfi, K., García, P., García, A., Garrido, A., Effect of cultivar and processing method on the contents of polyphenols in table olives. J. Agric. Food Chem. 52 (2004), 479–484.
20. [20] Radtke, J., Linseisen, J., Wolfram, G., Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Z. Ernahr. 37 (1998), 190–197.
21. [21] Williamson, G., Holst, B., Dietary reference intake (DRI) value for dietary polyphenols: are we heading in the right direction?. Br. J. Nutr. 99:Suppl. 3 (2008), S55–S58.
22. [22] Fki, I., Bouaziz, M., Sahnoun, Z., Sayadi, S., Antioxidant effect of phenolic compounds extracted from Chemlali olive cultivar in hypercholesterolemic rats. Bioorg. Med. Chem. 13 (2005), 5362–5370.
23. [23] Fki, I., Sahnoun, Z., Sayadi, S., Hypocholesterolemic effects of phenolic extracts and purified hydroxytyrosol recovered from olive mill wastewater in rats fed a cholesterol-rich diet. J. Agric. Food Chem. 55 (2007), 624–631.
24. [24] Covas, M.I., Nyyssönen, K., Poulsen, H.E., Kaikkonen, J., Zunft, H.J., Kiesewetter, H., Gaddi, A., de la Torre, R., Mursu, J., Bäumler, H., Nascetti, S., Salonen, J.T., Fitó, M., Virtanen, J., Marrugat, J., EUROLIVE Study Group, The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann. Intern. Med. 145 (2006), 333–341.
25. [25] Machowetz, A., Gruendel, S., Garcia, A.L., Harsch, I., Covas, M.I., Zunft, H.J., Koebnick, C., Effect of olive oil consumption on serum resistin concentrations in healthy men. Horm. Metab. Res. 40 (2008), 697–701, 10.1055/s-2008-1078728.
26. [26] Oliveras-López, M.J., Molina, J.J., Mir, M.V., Rey, E.F., Martín, F., de la Serrana, H.L., Extra virgin olive oil (EVOO) consumption and antioxidant status in healthy institutionalized elderly humans. Arch. Gerontol. Geriatr. 57 (2013), 234–242, 10.1016/j.archger.2013.04.002.
27. [27] S. Martín-Peláez, J. Mosele, N. Pizarro, M. Farràs, R. de la Torre, I. Subirana, F. Pérez-Cano, O. Castañer, R. Solà, S. Fernandez-Castillejo, S. Heredia, M. Farré, M. Motilva, M. Fitó Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota. Eur. J. Nutr. 2015; November 5, published online. doi: 10.1007/s00394-015-1063-2.
28. [28] Vázquez-Velasco, M.1, Esperanza Díaz, L., Lucas, R., Gómez-Martínez, S., Bastida, S., Marcos, A., Sánchez-Muniz, F.J., Effects of hydroxytyrosol-enriched sunflower oil consumption on CVD risk factors. Br. J. Nutr. 105 (2011), 1448–1452, 10.1017/S0007114510005015 (Epub 2010 Dec 8).
29. [29] Filip, R., Possemiers, S., Heyerick, A., Pinheiro, I., Raszewski, G., Davicco, M.J., Coxam, V., Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia. J. Nutr. Health Aging 19 (2015), 77–86, 10.1007/s12603-014-0480-x.
30. [30] Perrinjaquet-Moccetti, T., Busjahn, A., Schmidlin, C., Schmidt, A., Bradl, B., Aydogan, C., Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother. Res. 22 (2008), 1239–1242, 10.1002/ptr.2455.
31. [31] Susalit, E., Agus, N., Effendi, I., Tjandrawinata, R.R., Nofiarny, D., Perrinjaquet-Moccetti, T., Verbruggen, M., Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril. Phytomedicine 18 (2011), 251–258, 10.1016/j.phymed.2010.08.016.
32. [32] Crespo, M.C., Tomé-Carneiro, J., Burgos-Ramos, E., Loria Kohen, V., Espinosa, M.I., Herranz, J., Visioli, F., One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes. Pharm. Res. 95–96 (2015), 132–137, 10.1016/j.phrs.2015.03.018.
33. [33] Andjelkovic, M., Van Camp, J., Bruno De Meulenaer, B., Depaemelaere, G., Socaciu, C., Verloo, M., Verhe, R., Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food Chem., 98, 2006, 23, 10.1016/j.foodchem.2005.05.044.
34. [34] Salonen, J.T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R., Salonen, R., High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 (1992), 803–811.
35. [35] Hunnicutt, J., He, K., Xun, P., Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies. J. Nutr. 144 (2014), 359–366, 10.3945/jn.113.185124.
36. [36] Lapice, E., Masulli, M., Vaccaro, O., Iron deficiency and cardiovascular disease: an updated review of the evidence. Curr. Atheroscler. Rep., 15, 2013, 358.
37. [37] Ouyang, P., Gottlieb, S.H., Culotta, V.L., Navas-Acien, A., EDTA chelation therapy to reduce cardiovascular events in persons with diabetes. Curr. Cardiol. Rep., 17, 2015, 96, 10.1007/s11886-015-0656-y.
38. [38] Franchini, M., Targher, G., Montagnana, M., Lippi, G., Iron and thrombosis. Ann. Hematol. 87 (2008), 167–173.
39. [39] Chiva-Blanch, G., Urpi-Sarda, M., Ros, E., Valderas-Martinez, P., Casas, R., Arranz, S., Guillén, M., Lamuela-Raventós, R.M., Llorach, R., Andres-Lacueva, C., Estruch, R., Clin. Nutr. 32 (2013), 200–206, 10.1016/j.clnu.2012.08.022.
40. [40] Lemos, C., Peters, G.J., Jansen, G., Martel, F., Calhau, C., Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur. J. Nutr. 46 (2007), 329–336.
41. [41] Navarro-Perán, E., Cabezas-Herrera, J., García-Cánovas, F., Durrant, M.C., Thorneley, R.N., Rodríguez-López, J.N., The antifolate activity of tea catechins. Cancer Res. 65 (2005), 2059–2064.
42. [42] Sánchez-del-Campo, L., Sáez-Ayala, M., Chazarra, S., Cabezas-Herrera, J., Rodríguez-López, J.N., Binding of natural and synthetic polyphenols to human dihydrofolate reductase. Int J. Mol. Sci. 10 (2009), 5398–5410, 10.3390/ijms10125398.
43. [43] Halliwell, B., Gutteridge, J.M.C., Free Radicals in Biology and Medicine, 5th ed., 2015, Oxford University Press, Oxford.
44. [44] Laranjinha, J., Cadenas, E., Redox cycles of caffeic acid, alpha-tocopherol, and ascorbate: implications for protection of low density lipoproteins against oxidation. Life 48 (1999), 57–65.
45. [45] Covas, M.I., de la Torre, K., Farré-Albaladejo, M., Kaikkonen, J., Fitó, M., López-Sabater, C., Pujadas-Bastardes, M.A., Joglar, J., Weinbrenner, T., Lamuela-Raventós, R.M., de la Torre, R., Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic. Biol. Med. 40 (2006), 608–616.